Indications
Symptomatic relief of coughs caused by minor viral upper
respiratory tract infections or inhaled irritants.
Most effective for chronic nonproductive cough. A common
ingredient in nonprescription cough and cold
preparations.
Action
Suppresses the cough reflex by a direct effect on the
cough center in the medulla. Related to opioids structurally
but has no analgesic properties. Therapeutic
Effects: Relief of irritating nonproductive cough.
Pharmacokinetics
Absorption: Rapidly absorbed from the GI tract. Extended-
release product is slowly absorbed.
Distribution: Unknown. Probably crosses the placenta
and enters breast milk.
Metabolism and Excretion: Metabolized to dextrorphan,
an active metabolite. Dextromethorphan and
dextrorphan are renally excreted.
Half-life: Unknown.
TIME/ACTION PROFILE (cough suppression)
ROUTE ONSET PEAK DURATION
PO 15–30 min unknown 3–6 hr†
PO-ER unknown unknown 9–12 hr
†Up to 8 hr for gelcaps.
Contraindications/Precautions
Contraindicated in: Hypersensitivity; Patients taking
MAO inhibitors or SSRIs; Should not be used for
chronic productive coughs; Some products contain alcohol
and should be avoided in patients with known intolerance.
Use Cautiously in: Cough that lasts more than 1 wk
or is accompanied by fever, rash, or headache—
health care professional should be consulted; History of
drug abuse or drug-seeking behavior (capsules have
been abused resulting in deaths); Diabetes (some
products contain sucrose); OB: Pregnancy (has been
used safely); Lactation: Lactation; Pedi: Children 4 yr
(OTC cough and cold products containing this medication
should be avoided).
Adverse Reactions/Side Effects
CNS: high dose—dizziness, sedation. GI: nausea.
Interactions
Drug-Drug: Use with MAO inhibitors may result in
serotonin syndrome (nausea, confusion, changes in
BP); concurrent use should be avoided.qCNS depression
with antihistamines, alcohol, antidepressants,
sedative/hypnotics, or opioids. Amiodarone,
fluoxetine, or quinidine mayqblood levels
and adverse reactions from dextromethorphan.
Route/Dosage
PO (Adults and Children 12 yr): 10–20 mg q 4 hr
or 30 mg q 6–8 hr or 60 mg of extended-release preparation
bid (not to exceed 120 mg/day).
PO (Children 6–12 yr): 5–10 mg q 4 hr or 15 mg q
6–8 hr or 30 mg of extended-release preparation q 12
hr (not to exceed 60 mg/day).
PO (Children 4–6 yr): 2.5–5 mg q 4 hr or 7.5 mg q
6–8 hr or 15 mg of extended-release preparation q 12
hr (not to exceed 30 mg/day).
Availability (generic available)
Gelcaps: 30 mgOTC. Lozenges (cherry): 2.5 mgOTC, 5
mgOTC. Liquid (cherry, grape): 3.5 mg/5 mLOTC, 5
mg/5 mL, 7.5 mg/5 mLOTC, 15 mg/5mLOTC, 30 mg/5
mLOTC. Syrup (cherry, cherry bubblegum): 7.5 mg/
5 mLOTC, 15 mg/15 mLOTC, 10 mg/5 mLOTC. Extendedrelease
suspension (orange): 30 mg/5 mLOTC.
Drops (Grape): 7.5 mg/0.8 mLOTC, 7.5 mg/1 mLOTC.
Orally-disintegrating strips (cherry, grape): 7.5
mgOTC, 15mgOTC. In combination with: antihistamines,
decongestants, and expectorants in cough and
cold preparationsOTC, quinidine sulfate (Nuedextra).
See Appendix B.
No comments:
Post a Comment